Shanghai Juncell Therapeutics Co., Ltd.
PrivateLast Round
Series B
Apr 1, 2024
Total Funding Raised
$100.12M
Company Overview
Shanghai Juncell Therapeutics Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in April 2024.
Shanghai Juncell Therapeutics Co., Ltd. is a biotechnology company that develops innovative tumor-infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Juncell Therapeutics Co., Ltd. Comparables
Compare Shanghai Juncell Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeogenTC | 88% | |
| Grit Biotherapeutics | 87% | |
| Leman Biotech | 84% |
For institutional investors. Book with your work email.
Shanghai Juncell Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2024 | ||||
| Series A Extension | Jan 15, 2022 | ||||
| Series A | Feb 26, 2021 | ||||
| Pre Seed | Feb 21, 2020 |
For institutional investors. Book with your work email.
Shanghai Juncell Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Series A Extension, Series B, Series B Extension, Series A |
| YuanBio Venture Capital | Series A Extension, Series B Extension |
| ALAN Asset Management | Series A Extension |
| Medfine Capital | Series A |
| Oriza Seed Venture Capital | Series A Extension, Series C, Series B Extension, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2022
$24M round with participation from ALAN Asset Management and Kaitai Capital.
- Feb 26, 2021
$15.5M round led by Kaitai Capital.
For institutional investors. Book with your work email.
Shanghai Juncell Therapeutics Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Juncell Therapeutics Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Juncell Therapeutics Co., Ltd. a public or private company?
Shanghai Juncell Therapeutics Co., Ltd. is a private company.
What is the current stock price of Shanghai Juncell Therapeutics Co., Ltd.?
Shanghai Juncell Therapeutics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Juncell Therapeutics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Juncell Therapeutics Co., Ltd. worth (valuation)?
Valuation information for Shanghai Juncell Therapeutics Co., Ltd. is not publicly available.
Can I buy Shanghai Juncell Therapeutics Co., Ltd. stock?
Shanghai Juncell Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Juncell Therapeutics Co., Ltd.'s last funding round?
Shanghai Juncell Therapeutics Co., Ltd.'s most recent funding round was Series B on April 1, 2024.
Who are the main investors in Shanghai Juncell Therapeutics Co., Ltd.?
Key investors in Shanghai Juncell Therapeutics Co., Ltd. include Kaitai Capital, Oriza Seed Venture Capital.
Will Shanghai Juncell Therapeutics Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Juncell Therapeutics Co., Ltd..
How can I track Shanghai Juncell Therapeutics Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Juncell Therapeutics Co., Ltd.'s shares on secondary markets.